The EPO published application EP3316862A1 titled 'Edible Plant-Derived Microvesicle Compositions for Delivery of miRNA and Methods for Treatment of Cancer.' The invention relates to compositions comprising microvesicles derived from edible plants, where the microvesicles contain miRNA payloads for therapeutic delivery to cancer cells. The application is classified under A61K 9/127 (liposomal compositions), A61P 35/00 (antineoplastic agents), and C12N 15/113 (nucleic acid sequences). Designated states include all major EPO member states across the EU.

This is a patent publication notice, not a regulatory requirement. Compliance teams monitoring pharmaceutical IP trends should note this publication for competitive landscape analysis in the miRNA delivery space. No immediate action is required unless your organization is developing similar technologies where this patent may affect freedom-to-operate considerations.